Suchergebnisse - "Ziepert, Marita"

PubPharm (35)

1

Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphoma

enthalten in: Leukemia & lymphoma | 2021

von Nordmo, C. | Glehr, G. | Altenbuchinger, M. | +11

2

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

enthalten in: Blood | 2021

von Schmitz, N. | Truemper, L. | Bouabdallah, K. | +38

CommentIn: Blood. 2021 May 13;137(19):2570-2571. - PMID 33983423

3

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma : the DSHNHL2006-1B/ACT-2 trial

enthalten in: Leukemia | 2021

von Wulf, G. | Altmann, B. | Ziepert, M. | +26

4

International prognostic indices in diffuse large B-cell lymphoma : a comparison of IPI, R-IPI, and NCCN-IPI

enthalten in: Blood | 2020

von Ruppert, A. | Dixon, J. | Salles, G. | +11

CommentIn: Blood. 2020 Jun 4;135(23):2014-2015. - PMID 32497224

5

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2019

von Poeschel, V. | Held, G. | Ziepert, M. | +43

CommentIn: Lancet. 2020 Dec 21;394(10216):2208-2209. - PMID 31868615

6

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma : A Study by the Lunenburg Lymphoma Biomarker Consortium

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Rosenwald, A. | Bens, S. | Advani, R. | +33

7

Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial

enthalten in: British journal of haematology | 2019

von Friedrichs, B. | Nickelsen, M. | Ziepert, M. | +12

8

Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

enthalten in: Blood | 2018

von Thurner, L. | Preuss, K. | Bewarder, M. | +26

CommentIn: Blood. 2018 Dec 27;132(26):2704-2706. - PMID 30591542

9

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma : An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Shi, Q. | Schmitz, N. | Ou, F. | +16

CommentIn: J Clin Oncol. 2019 Feb 20;37(6):525-526. - PMID 30592639

10

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

enthalten in: Nature medicine | 2018

von Chapuy, B. | Stewart, C. | Dunford, A. | +43

ErratumIn: Nat Med. 2018 Aug;24(8):1292. - PMID 29955181